Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
91.79 USD | +0.69% | +1.54% | -3.44% |
Apr. 24 | Earnings Flash (AMED) AMEDISYS Reports Q1 EPS $1.03 | MT |
Apr. 24 | Amedisys, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- With a 2024 P/E ratio at 25.89 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.44% | 3B | B- | ||
0.00% | 1.81B | - | ||
+49.28% | 624M | D+ | ||
-3.09% | 503M | - | ||
-35.42% | 368M | - | ||
-34.25% | 139M | - | ||
-13.04% | 136M | - | ||
+1.92% | 67.7M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- AMED Stock
- Ratings Amedisys, Inc.